Literature DB >> 16422782

A comparison of multivariable regression models to analyse cost data.

Susanna Dodd1, Asish Bassi, Keith Bodger, Paula Williamson.   

Abstract

RATIONALE, AIMS AND
OBJECTIVES: Analysis of cost data is important in providing reliable information to aid budgeting decisions. Certain features of cost data, such as its typically highly skewed distribution and the need to estimate arithmetic mean costs in order to allow inferences to be made on total costs, make it difficult to analyse. Multivariable regression analysis is useful for estimating the influence of explanatory variables on cost in order to predict costs of future patients and allows for the control of variables which influence cost but whose distributions differ between comparison groups. This is especially important in the case of observational studies, where there may be no control over the balance of characteristics between the comparison groups.
METHOD: This paper compares the appropriateness of various multivariable models of cost data by examining regression diagnostics, using as an example data collected on costs incurred in the treatment of inflammatory bowel disease. The models compared are normal and bootstrapped multiple linear regression, median regression, gamma model with the log link and normal linear regression (NLR) of log costs.
RESULTS: Gamma modelling with the log link was found to be the most suitable model.
CONCLUSIONS: Bootstrapping was found to make very little difference to conclusions from the NLR model.

Entities:  

Mesh:

Year:  2006        PMID: 16422782     DOI: 10.1111/j.1365-2753.2006.00610.x

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  54 in total

1.  Factors Associated with Length of Stay in a Swiss Mental Hospital.

Authors:  Benedikt Habermeyer; Hristijana De Gennaro; Rene Channa Frizi; Patrik Roser; Niklaus Stulz
Journal:  Psychiatr Q       Date:  2018-09

2.  Annual costs attributed to atrial fibrillation management: cross-sectional study of primary healthcare electronic records.

Authors:  Marc Casajuana; Maria Giner-Soriano; Albert Roso-Llorach; Cristina Vedia; Concepció Violan; Rosa Morros
Journal:  Eur J Health Econ       Date:  2018-02-20

3.  Variation in treatment of neonatal abstinence syndrome in US children's hospitals, 2004-2011.

Authors:  S W Patrick; H C Kaplan; M Passarella; M M Davis; S A Lorch
Journal:  J Perinatol       Date:  2014-06-12       Impact factor: 2.521

4.  EVALUATING COSTS WITH UNMEASURED CONFOUNDING: A SENSITIVITY ANALYSIS FOR THE TREATMENT EFFECT.

Authors:  Elizabeth A Handorf; Justin E Bekelman; Daniel F Heitjan; Nandita Mitra
Journal:  Ann Appl Stat       Date:  2013       Impact factor: 2.083

5.  Trends and determinants of costs associated with the inpatient care of diabetic foot ulcers.

Authors:  Caitlin W Hicks; Shalini Selvarajah; Nestoras Mathioudakis; Bruce A Perler; Julie A Freischlag; James H Black; Christopher J Abularrage
Journal:  J Vasc Surg       Date:  2014-06-14       Impact factor: 4.268

6.  Excess direct medical costs of severe obesity by socioeconomic status in German adults.

Authors:  Thomas von Lengerke; Jürgen John; Andreas Mielck
Journal:  Psychosoc Med       Date:  2010-04-20

7.  Improving the evidence base of Markov models used to estimate the costs of scaling up antiretroviral programmes in resource-limited settings.

Authors:  Rory Leisegang; Gary Maartens; Michael Hislop; Leon Regensberg; Susan Cleary
Journal:  BMC Health Serv Res       Date:  2010-07-02       Impact factor: 2.655

8.  Disparities in Potentially Preventable Emergency Department Visits for Children with Asthma among Asian Americans, Pacific Islanders, and Whites in Hawai'i.

Authors:  Olivia Uchima; Deborah A Taira; Hyeong Jun Ahn; So Yung Choi; May Okihiro; Tetine Sentell
Journal:  Int J Environ Res Public Health       Date:  2021-07-02       Impact factor: 3.390

9.  Effectiveness of the psychological and pharmacological treatment of catastrophization in patients with fibromyalgia: a randomized controlled trial.

Authors:  Javier García-Campayo; Antoni Serrano-Blanco; Baltasar Rodero; Rosa Magallón; Marta Alda; Eva Andrés; Juan V Luciano; Yolanda López del Hoyo
Journal:  Trials       Date:  2009-04-23       Impact factor: 2.279

10.  Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis.

Authors:  Rory Leisegang; Susan Cleary; Michael Hislop; Alistair Davidse; Leon Regensberg; Francesca Little; Gary Maartens
Journal:  PLoS Med       Date:  2009-12-01       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.